Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma

Condition:   Nasopharyngeal Carcinoma
Interventions:   Drug: Ipilimumab;   Drug: Nivolumab
Sponsors:   National Cancer Centre, Singapore;   National University, Singapore
Not yet recruiting - verified March 2017

http://ift.tt/2nnAggw